All Releases
 |
CombiMatrix Corporation Reports Third Quarter 2011 Financial Results
Nov 10, 2011
|
45.6 KB |
|
| |
IRVINE, Calif., Nov. 10, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, reported today that total revenues for the third quarter of 2011 increased 20% to $1.2 million from $1.0 million in the third quarter of 2010. Diagnost...
|
|
CombiMatrix Corporation to Release Third Quarter and Nine-Month Financial Results on November 10, 2011
Nov 3, 2011
|
12.4 KB |
|
| |
IRVINE, Calif., Nov. 3, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its third quarter and nine-month 2011 financial results on Thursday, November 10, 2011. Results will be released prior to trading on that day.
A conference call has also been scheduled regarding CombiMatrix Corporation...
|
|
David H. Ledbetter, PH.D., FACMG Joins CombiMatrix Medical Advisory Board
Oct 4, 2011
|
26.1 KB |
|
| |
IRVINE, Calif., Oct. 4, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that chromosomal microarray leader and expert David H. Ledbetter, Ph.D., FACMG, has joined CombiMatrix's Medical Advisory Board.
...
|
|
CombiMatrix Names Jeff Hayes Director of Sales for Oncology
Sep 6, 2011
|
35.2 KB |
|
| |
IRVINE, Calif., Sept. 6, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that diagnostics industry veteran Jeff Hayes has been named Director of Sales for the Oncology market. Hayes brings more than 20 years ...
|
|
CombiMatrix to Present at the 2011 Southern California Investor Conference
Aug 22, 2011
|
33.7 KB |
|
| |
IRVINE, Calif., Aug. 22, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that management is scheduled to make an investor presentation at the 2011 Southern California Investor Conference on Monday, August 29,...
|
|
CombiMatrix Corporation Reports Second Quarter 2011 Financial Results
Aug 10, 2011
|
45.2 KB |
|
| |
IRVINE, Calif., Aug. 10, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, reported today that total revenues for the second quarter of 2011 increased 32% to $1.2 million from $916,000 in the second quarter of 2010. Sequential...
|
|
CombiMatrix Receives New York State Clinical Laboratory Permit
Aug 8, 2011
|
36.5 KB |
|
| |
IRVINE, Calif., Aug. 8, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has received its Clinical Laboratory Permit from the New York State Department of Health. The permit allows the Company to immediately begin receiving specimens for DNAarray™ Postnatal Developmental Testing. The DNAarray tests are ba...
|
|
CombiMatrix Corporation to Release Second Quarter and Six-Month Financial Results on August 10, 2011
Aug 3, 2011
|
12.4 KB |
|
| |
IRVINE, Calif., Aug. 3, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its second quarter and six-month 2011 financial results on Wednesday, August 10, 2011. Results will be released at the beginning of trading on that day.
A conference call has also been scheduled regarding CombiMatrix C...
|
|
CombiMatrix Corporation Reports First Quarter 2011 Financial Results
May 11, 2011
|
45.0 KB |
|
| |
IRVINE, Calif., May 11, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, reported today that total revenues for the first quarter of 2011 increased 11% to $913,000 from $820,000 in the first quarter of 2010. First quarter 201...
|
|
CombiMatrix Corporation to Release First Quarter Financial Results on May 11, 2011
May 4, 2011
|
35.9 KB |
|
| |
IRVINE, Calif., May 4, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its first quarter 2011 financial results on Wednesday, May 11, 2011. Results will be released at the close of trading on that day.
A conference call has also been scheduled regarding CombiMatrix Corporation's first qua...
|
|
CombiMatrix Partners With Clarient to Commercialize CombiMatrix Genomic Profile Tests for Cancer
Apr 11, 2011
|
37.8 KB |
|
| |
IRVINE, Calif., April 11, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has entered into a strategic partnership with Clarient, Inc., a GE Healthcare Company, that allows Clarient the right to commercialize the CombiMatrix DNAarray™ product portfolio. The DNAarray tests are based on aCGH technology, wh...
|
|
CombiMatrix Closes $6.7 Million Private Placement of Common Stock and Warrants
Apr 7, 2011
|
38.4 KB |
|
| |
IRVINE, Calif., April 7, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics laboratory offering genetic array testing, a comprehensive profiling of chromosomes and genes used to classify and assist in the treatment of cancer and developmental disorders, announced today that it has closed its private placement, i...
|
|
CombiMatrix Raising $6.76 Million in Private Placement of Common Stock and Warrants
Apr 4, 2011
|
32.2 KB |
|
| |
IRVINE, Calif., April 4, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has entered into securities purchase agreements with accredited investors to sell $6.76 million of newly-issued shares of its common stock and warrants in a private placement.
Under the terms of the transaction, CombiMatrix will s...
|
|
CombiMatrix Corporation Reports Fourth Quarter and Year End 2010 Financial Results
Feb 24, 2011
|
45.7 KB |
|
| |
IRVINE, Calif., Feb. 24, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, reported today that total revenues for the fourth quarter of 2010 increased 26 percent to $804,000 from $637,000 in the fourth quarter of 2009. For 201...
|
|
CombiMatrix Corporation to Release Fourth Quarter Financial Results on February 24, 2011
Feb 17, 2011
|
36.0 KB |
|
| |
IRVINE, Calif., Feb. 17, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its fourth quarter 2010 financial results on Thursday, February 24, 2011. Results will be released at the close of trading on that day.
A conference call has also been scheduled regarding CombiMatrix Corporation's fo...
|
|
CombiMatrix Receives Acceptance Notice for Listing on the Nasdaq Capital Market; Hires New Director of Sales
Dec 9, 2010
|
34.7 KB |
|
| |
IRVINE, Calif., Dec. 9, 2010 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it has received a notice from The Nasdaq Stock Market approving the Company's application to voluntarily transfer listing of the Company's securities to The Nasdaq Capital Market from The Nasdaq Global Market, and indicating that such transfe...
|
|
CombiMatrix Corporation to Voluntarily Apply to Transfer Listing of Its Securities to the NASDAQ Capital Market
Dec 2, 2010
|
34.4 KB |
|
| |
IRVINE, Calif., Dec. 2, 2010 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that its Board of Directors has authorized management to proceed with voluntarily applying to transfer the listing of the Company's securities to The Nasdaq Capital Market rather than submitting a plan to regain compliance with The Nasdaq Global M...
|
|
CombiMatrix Corporation Receives Nasdaq Notice Regarding Stockholders' Equity
Nov 19, 2010
|
35.6 KB |
|
| |
IRVINE, Calif., Nov. 19, 2010 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) today announced that it received a written notice from The Nasdaq Stock Market (the "Notice") on November 17, 2010 indicating that the Company is not in compliance with the minimum stockholders' equity requirement for continued listing on The Nasdaq Global Marke...
|
|
CombiMatrix Corporation Reports Third Quarter 2010 Financial Results
Nov 10, 2010
|
44.5 KB |
|
| |
IRVINE, Calif., Nov. 10, 2010 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company with a focus on DNA-based clinical diagnostic testing services for oncology and pre-and postnatal developmental disorders, reported today that revenues for the third quarter of 2010 increased 68 percent to $1.0 million from $603,...
|
|
CombiMatrix Corporation Awarded $488,958 Grant Under IRS Section 48D for Qualifying Therapeutic Discovery Projects
Nov 4, 2010
|
35.7 KB |
|
| |
IRVINE, Calif., Nov. 4, 2010 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company with a focus on DNA-based clinical diagnostic testing services for oncology and pre-and postnatal developmental disorders, announced today the award of $488,958 under the Internal Revenue Service's Section 48D for Qualifying Thera...
|
|
|
